Efficacy of Tranexamic Acid in Reducing Blood Loss in Lower Segment Cesearean Section: A Randomised Controlled Study
Tóm tắt
To determine the efficacy of tranexamic acid in decreasing blood loss in elective/emergency LSCS. A prospective randomised case control study was done in 200 pregnant women undergoing elective/emergency LSCS in the Department of Obstetrics and Gynaecology, at a tertiary care teaching hospital in Mysuru, from December 2018 to September 2019. Women in the age group of 18–35 years were included in the study. Those with anaemia (Hb < 10 gm%), hypertension in pregnancy, bleeding diathesis, GDM on insulin, polyhydramnios, oligohydramnios, cardiac and chronic liver disorders were excluded from the study. Two hundred women undergoing emergency/elective LSCS were divided into case (group 1) or control (group 2) groups using a computer-generated random number table. Tranexamic acid (10 mg/Kg) was given in 100 ml Normal Saline 10 mins prior to skin incision to women in the first group, along with routine care (10 Units of Oxytocin IM soon after extraction of the baby). Routine care, as per institutional protocol, was followed in the second group. The primary outcome was to estimate the intraoperative blood loss. Blood loss was measured by weighing pads, mops, drapes before and after surgery and blood in the suction container after surgery. Two separate suction catheters and containers were used, in order to minimise mixing of blood and amniotic fluid. Total blood loss was calculated as the difference in the weight of the pads, mops and drapes before and after surgery and the sum of the amount of blood in suction container. The difference between the pre-operative and post-operative haemoglobin and haematocrit was compared. The pre-operative, intra-operative and post-operative hemodynamics were also compared. Statistical analysis was done using MS Excel and R-3.5.1 software. Unpaired and paired t test were used. In our study, there was a significant decrease in intraoperative bleeding in women receiving tranexamic acid. Women in the control group had a significant fall in the postoperative hemoglobin when compared to women who received tranexamic acid. Also, women who received tranexamic acid did not develop any significant hemodynamic changes during or immediately after the surgery. Tranexamic acid can be safely used as a prophylactic agent to reduce bleeding during elective and emergency LSCS.
Tài liệu tham khảo
Dhivya SJ, Reena A, et al. Role of tranexamic acid in reducing blood loss during elective LSCS: A randomized controlled study in 2016. J Clin Diagn Res. 2016;10(12):QC17–QC21.
Babita R, Nayak L, et al. Intravenous 1gm tranexamicacid for prevention of blood loss and blood transfusion during caesarean section:a randomized case control study. Int J Reprod Contracept Obstet Gynaecol. 2014;3(2):366–9.
Ker K, Edwards P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
The CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23–322.
Binz S, McCollester J, Thomas S, et al. CRASH-2 study of tranexamic acid to treat bleeding in trauma patients: a controversy fueled by science and social media. J Blood Transfus. 2015;2015:874920. https://doi.org/10.1155/2015/874920.
Sampathkumari S, et al. A study on efficacy of prophylactic tranexamic acid in reducing blood loss during elective Lscs. IOSR J Dent Med Sci. 2018;17(2):59–63.
Abdel-Aleem H, Alhusaini TK, AbdelAleem MA, Menoufy M, Gülmezoglu AM. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: Randomized clinical trial. J Matern Fetal Neonatal Med. 2013;26(1):1705–9.
Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet. 2013;287(3):463–8.
Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. “Military application of tranexamic acid in trauma emer-gency resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113–9.
World Health Organization (WHO). WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO; 2012.
Gungorduk K, Yildirim G, Asicioglu O, Ark C. Efficacy of intravenous Tranexamic acid in reducing blood loss after elective cesarean section: a prospective randomized double blind placebo controlled study. Am J Prenatal. 2011;28(3):233–40.
Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F, et al. Study protocol: TRAAP-TRAnexamic Acid for Preventing postpartum haemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Preg Childbirth. 2015;15(1):1.
WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum hemorrhage(WOMAN): an international, randomized, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16.
Updated WHO recommendation on Tranexamic acid for the treatment of Postpartum Hemorrhage. Highlights and Key Messages from the World Health Organization’s 2017 Global Recommendations. 2017.
Massimo F, Carlo M, et al. Safety and efficacy of tranexamic acid for prevention of obstetric hemorrhage: An updated systemic review and meta analysis. Blood Trans. 2018;16(4):329–37.
Khadilkar SS, Sood A, Ahire P. Quantification of Peri-partum Blood Loss: Training Module and Clot Conversion Factor. J Obstet Gynecol India. 2016;66:307–14.
Schorn MN. Measurement of blood loss: review of the literature. J Midwifery Womens Health. 2010;55(1):20–7.